CLC Number:
| [1] Tsui WM, Loo KT, Chow LT, et al. Biliary adenofibroma. A heretofore unrecognized benign biliary tumor of the liver[J]. Am J Surg Pathol,1993,17(2):186-192. [2] Godambe A, Brunt EM, Fulling KH, et al. Biliary adenofibroma with invasive carcinoma: case report and review of the literature[J]. Case Rep Pathol,2016,2016:8068513. doi: 10.1155/2016/8068513. [3] Parada LA, Bardi G, Hallén M, et al. Monosomy 22 in a case of biliary adenofibroma[J]. Cancer Genet Cytogenet, 1997,93(2):183-184. [4] Arnason T, Borger DR, Corless C, et al. Biliary adenofibroma of liver: morphology, tumor genetics, and outcomes in 6 cases[J]. Am J Surg Pathol, 2017,41(4):499-505. [5] Lee S, Kim KW, Jeong WK, et al. Magnetic resonance imaging findings of biliary adenofibroma[J]. Korean J Gastroenterol,2019,74(6):356-361. [6] Akin O, Coskun M. Biliary adenofibroma with malignant transformation and pulmonary metastases: CT findings[J]. Am J Roentgenol, 2002,179(1):280-281. [7] Nguyen NT, Harring TR, Holley L, et al. Biliary adenofibroma with carcinoma in situ: a rare case report[J]. Case Reports Hepatol, 2012,2012:793963.doi: 10.1155/2012/793963. [8] Kai K, Yakabe T, Kohya N, et al. A case of unclassified multicystic biliary tumor with biliary adenofibroma features[J]. Pathol Int, 2012,62(7):506-510. [9] Tsutsui A, Bando Y, Sato Y, et al. Biliary adenofibroma with ominous features of imminent malignant changes[J]. Clin J Gastroenterol, 2014,7(5):441-448. [10] Jacobs MA, Lanciault C, Weinstein S. Incidental biliary adenofibroma with dysplastic features[J]. BJR Case Rep,2015,1(2):20150100. [11] Thai E, Dalla Valle R, Evaristi F, et al. A case of biliary adenofibroma with malignant transformation[J]. Pathol Res Pract, 2016,212(5):468-470. [12] Thompson SM, Zendejas-Mummert B, Hartgers ML, et al. Malignant transformation of biliary adenofibroma: a rare biliary cystic tumor[J]. J Gastrointest Oncol,2016,7(6):107-112. [13] Kaminsky P, Preiss J, Sasatomi E, et al. Biliary adenofibroma: a rare hepatic lesion with malignant features[J]. Hepatology,2017,65(1):380-383. [14] Chua D, Chiow AKH, Ang TL, et al. Malignant transformation arising within unusual and rare hepatic lesions: fibropolycystic disease form of ductal plate malformation and biliary adenofibroma[J]. Int J Surg Pathol,2018,26(6):542-550. [15] 徐仟, 刘红刚, 何春燕.肝内胆管腺纤维瘤伴恶变临床病理观察[J]. 诊断病理学杂志,2018,25(3):196-200. XU Qian, LIU Honggang, HE Chunyan. Clinico-pathological characteristics of intrahepatic biliary adenofibroma with malignant transformation[J]. Chinese Journal of Diagnostic Pathology, 2018,25(3):196-200. [16] 祁秀敏, 姜春娟. 肝脏胆管腺纤维瘤一例[J]. 中华病理学杂志,2019,48(2):154-155. QI Xiumin, JIANG Chunjuan. Biliary adenofibroma of liver: report of a case[J]. Chinese Journal of Pathology, 2019, 48(2): 154-155. [17] Sturm AK, Welsch T, Meissner C, et al. A case of biliary adenofibroma of the liver with malignant transformation: a morphomolecular case report and review of the literature[J]. Surg Case Rep, 2019,5(1):104. |
| [1] | LI Xiangze, WANG Xianming, SONG Gesheng, CUI Jing, SUN Kai, WANG Haochen, WANG Tiancheng, HAN Shaoqi, TIAN Hu. Hepatic epithelioid hemangioendothelioma complicated with hepatitis B cirrhosis: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 89-95. |
| [2] | SUN Yifeng, GAO Yu, LIANG Yongyuan, GAO Yang. Expression of CPLX2 and its in vitro effects on the proliferation migration and invasion of hepatocellular carcinoma cells [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 34-39. |
| [3] | WANG Ningning, QU Linli, CAO Fangli, LIANG Lei. Application of computed tomography sagittal reconstruction for microwave ablation of hepatic carcinoma under the diaphragm [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 71-75. |
| [4] | FANG Feifei, ZHANG Ying, LIN Qi, YUAN Yuan, DAI Jianjian, XU Ruicai, GENG Baocheng, HAN Mingyong. Clinical efficacy of CT-guided 125I seed brachytherapy in the treatment of metastatic hepatic carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(12): 53-57. |
| [5] | WANG Wei, CAO Yushan, SUN Daquan, HUANG Xiaoqiong, XU Guoqiang. Role of human TIMP-2 protein in the migration and invasion of hepatocellular carcinoma cell [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 11-17. |
| [6] | HE Wubin, SU Rongjian. Pulsatilla saponin D combined with sorafenib against hepatocellular carcinoma cell invasion and metastasis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 18-22. |
| [7] | LIU Juan, HAN Guoqing, LIU Hui, QIN Chengyong. Mechanism of human umbilical cord mesenchymal stem cells suppressing cholangiocarcinoma cell growth [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(8): 1-5. |
| [8] | ZHANG Jizong1,2, MENG Jiuda2, DING Hai2, YI Yongxiang2, YU Zeqian3, ZHOU Jiahua3. Diagnostic value of aspartate beta-hydroxylase combined with AFP and GP73 for hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 78-80. |
| [9] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(2): 106-108. |
| [10] | MENG Hai-peng, NIU Wei-bo, WU Xiao-peng, GUO Sen, LIU Yi, CHEN Yu-xin. Effects of type of PVTT on long-term outcomes of surgical treatment for hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 61-66. |
| [11] | XU Wei, CHANG Hong, ZHAI Yun-peng. Construction of Livin shRNA eukaryotic expression vector and its influence on chemotherapeutic sensitivity of HepG2 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 20-24. |
| [12] | CHEN Yuan-hong1, ZENG Yi1, LUO Yan-hong2. Effect of Rabdosia lophanthoides on the proliferation and apoptosis in hepatoma carcinoma cell line HepG2 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 42-45. |
| [13] | LI Heng1, LI Zhe1, QIAO Xiao-jun1, GAO Ai-qin2, ZHANG Nan2. Expressions of centrosome α tubulin, P53 protein and telomerase in hepatocarcinoma and their correlations [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(8): 74-77. |
| [14] | WANG Meng1, LIU Yan2, LI Jie2, SHI Dan-dan2， LIU Cong-cong2. Phantom investigation of the factors affecting the intensity of the twinkling artifact [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(8): 53-57. |
| [15] | FAN Hai-yan， ZHANG Hui-jing， GUO Zhan-jun， LI Sheng-mian. Prognostic significance of RASSF1A and WIF-1 methylation in the cancer tissues of patients with HCC [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 89-93. |
|
